Why National Marijuana Legalization Could Rest on California's Shoulders
The world has a new largest legal weed market in California. Cannabis Culture's Jodie Emery joins Cheddar to breakdown how the legalization rollout is going just one day into its implementation. She explains how the state is celebrating and if it's ready for the big change.
Despite all the headlines, California's streets aren't paved with green just yet. Emery explains why legal dispensaries will be slow to pop up around the Golden State. She also considers whether America's new cash crop might be taxed into oblivion.
Finally, the editor-in-chief places California in the context of the national legalization effort. She discusses just how much pressure the state finds itself under as a test case for other states. We look ahead to which other states might be next to follow in California's footsteps.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.